Health CarePharmaceuticals & Biotechnology
  • Price (JPY)4,293.00
  • Today's Change-114.00 / -2.59%
  • Shares traded7.73m
  • 1 Year change-30.71%
  • Beta0.6299
Data delayed at least 20 minutes, as of Nov 16 2018 06:00 GMT.
More ▼

Key statistics

On Friday, Takeda Pharmaceutical Co Ltd (4502:TYO) closed at 4,293.00, 2.14% above its 52-week low of 4,203.00, set on Jun 20, 2018.
52-week range
4,203.00Jun 20 20186,693.00Jan 10 2018
Markit short selling activity
Previous close4,407.00
Average volume5.71m
Shares outstanding794.70m
Free float773.43m
P/E (TTM)24.70
Market cap3.50tn JPY
EPS (TTM)178.40
Annual div (ADY)180.00
Annual div yield (ADY)4.08%
Div ex-dateSep 26 2018
Div pay-dateDec 03 2018
Next div ex-dateMar 27 2019
Next div pay-date--
Data delayed at least 20 minutes, as of Nov 16 2018 06:00 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.